scispace - formally typeset
C

Candelaria Gomez-Manzano

Researcher at University of Texas MD Anderson Cancer Center

Publications -  164
Citations -  16911

Candelaria Gomez-Manzano is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Oncolytic virus & Glioma. The author has an hindex of 45, co-authored 141 publications receiving 14610 citations. Previous affiliations of Candelaria Gomez-Manzano include University of Texas System & University of Texas Health Science Center at Houston.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

Juan Fueyo, +9 more
- 06 Jan 2000 - 
TL;DR: The results suggest that the E1A-mutant Δ24 adenovirus may be clinically and therapeutically useful against gliomas and possibly other cancers with disrupted Rb pathway.
Journal ArticleDOI

Tumor-associated stromal cells as key contributors to the tumor microenvironment

Karen M. Bussard, +5 more
- 11 Aug 2016 - 
TL;DR: The current literature pertaining to the origins of recruited host stroma, contributions toward tumor progression, tumor-associated stromal cells, and mechanisms of crosstalk between endogenous hostStroma and tumor cells are reviewed.
Journal ArticleDOI

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.

Frederick F. Lang, +22 more
- 12 Feb 2018 - 
TL;DR: Treatment with DNX-2401 resulted in dramatic responses with long-term survival in recurrent high-grade gliomas that are probably due to direct oncolytic effects of the virus followed by elicitation of an immune-mediated antiglioma response.